Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Here is what we know about common combinations and whether they affect onset or effectiveness
Presented for research literature review only Meca AD et al
10.1002/biof.5520270101 6 BargagliE.OlivieriC.BennettD.PrasseA.Muller-QuernheimJ.RottoliP
Contact your GP, diabetes specialist nurse or NHS 111 if you experience: Persistent vomiting lasting more than 24 hours or preventing adequate fluid intake this increases the risk of dehydration and acute kidney injury Severe abdominal pain , particularly if constant, worsening, or accompanied by fever this may indicate pancreatitis, a rare but serious adverse effect Signs of dehydration including dark urine, dizziness, reduced urination, dry mouth, or confusion Inability to tolerate any food or fluids for more than 24 hours Blood in vomit or stools this requires urgent assessment Severe or worsening constipation lasting more than three days despite management strategies Right upper abdominal pain, fever or yellowing of the skin/eyes these may indicate gallbladder problems, which can occur with tirzepatide Seek emergency medical attention (call 999 or attend A&E) if you develop: Severe, persistent abdominal pain radiating to the back, which could indicate acute pancreatitis Signs of severe dehydration with altered consciousness or inability to stand Symptoms of bowel obstruction severe bloating, inability to pass wind or stools, and vomiting Patients should also inform their healthcare provider if digestive symptoms significantly impact quality of life or persist beyond the first 46 weeks of treatment at a stable dose
